Financials
- Market Capitalization 777.79 M
- Employee 113
- Founded 2009
- CEO N/A
- Website www.aurabiosciences.com
- Headquarter Delaware, United States
- FIGI BBG00226DGM5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.1
ratio cours/chiffre d'affaires
49.59
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2617 | DBVT DBV Technologies S.A. - American Depositary Shares | 13.64 USD | -5.34% | -6.38% | -0.58% | +43.58% | 807.66 M USD | ||
| 2625 | FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 14.24 USD | -4.49% | -11.99% | +45.01% | +26.02% | 786.68 M USD | ||
| 2662 | NGNE Neurogene Inc. - Common Stock | 37.86 USD | -1.43% | -0.81% | +16.17% | +28.69% | 757.63 M USD | ||
| 2669 | MNPR Monopar Therapeutics Inc. - Common Stock | 109.60 USD | -3.81% | +3.97% | -0.80% | +100.66% | 735.65 M USD |